Article
The impact of breast cancer polygenic risk score disclosure on decisional conflict around risk-reducing mastectomy in women with pathogenic BRCA1/2 variants.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Aug 2026
Ongaro Giulia, Salafia Caroline, Sheikh Rania, Schofield Elizabeth, Clark Dana Farengo, Ebrahimzadeh Jessica, Chittenden Anu, Stopfer Jill E, Brower Jamie, Symecko Heather, Ovadia Hannah, Husband Alexander, Barr Hadley, Mukherjee Semanti, Hay Jennifer L, Stadler Zsofia K, Offit Kenneth, Garber Judy E, Domchek Susan M, Robson Mark E, Hamilton Jada G
Abstract excerpt
PURPOSE: Women with BRCA1/2 pathogenic variants (PVs) face high breast cancer risks and complex preventive decisions, including whether to undergo risk-reducing mastectomy, which can generate decisional conflict. Polygenic risk scores (PRSs) offer individualized risk estimates that may support informed preventive decisions. We examined whether PRS disclosure reduces decisional conflict about risk-reducing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
